Protection against lethal subcutaneous challenge of virulent Y. pestis strain 141 using an F1-V subunit vaccine

Science in China, Series C: Life Sciences

Volumn 50, Issue 5, 2007, Pages 600-604

  Wang, Dong ^a   Jia, Nuan ^b   Li, Peng ^a,c   Xing, Li ^a   Wang, XiLiang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Hospital Affiliated to Aeromedicine Institute of PLA   (China)

Author keywords

Challenge; F1 V fusion protein; Subunit vaccine; Yersinia pestis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN G; PLAGUE VACCINE; SUBUNIT VACCINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CHEMISTRY; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG LAVAGE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PLAGUE; T LYMPHOCYTE; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; VACCINES, SUBUNIT; YERSINIA PESTIS;

MUS; YERSINIA PESTIS;

EID: 34648816082     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-007-0071-8     Document Type: Article

References (20)

1. Meyer K F. Effectiveness of live or killed plague vaccines in man. Bull WHO, 1970, 42(5): 653-666
2. Williams J E, Altieri P L, Berman S, et al. Potency of killed plague vaccines prepared from avirulent Yersinia pestis. Bull WHO, 1980, 58(5): 753-756
3. Russell P, Eley S M, Hibbs S E, et al. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine, 1995, 13(16): 1551-1556
4. Williamson E D, Eley S M, Stagg A J, et al. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague. Vaccine, 1997, 15(10): 1079-1084
5. Williamson E D, Vesey P M, Gilhespy K J, et al. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol, 1999, 116(1): 107-114
6. Williamson E D, Eley S M, Griffin K F, et al. A new improved sub-unit vaccine for plague: The basis of protection. FEMS Immunol Med Microbiol, 1995, 12(3-4): 223-230
7. Leary S E C, Williamson E D, Griffin K F, et al. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect Immun, 1995, 63(8): 2854-2858
8. Titball R W, Williamson E D. Vaccination against bubonic and pneumonic plague. Vaccine, 2001, 19(30): 4175-4184
9. Perry R D, Fetherston J D. Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev, 1997, 10(1): 35-66
10. Andrews G P, Heath D G, Anderson G W Jr, et al. Fraction I capsular antigen (F1) purification from Yersinia pestis CO92 and an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun, 1996, 64(6): 2180-2187
11. Heath D G, Anderson G W Jr, Mauro J M, et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine, 1998, 16(11-12): 1131-1137
12. Williamson E D, Sharp G J E, Eley S M, et al. Local and systemic immune response to a microencapsulated subunit vaccine for plague. Vaccine, 1996, 14(17-18): 1613-1619
13. Anderson G W Jr, Leary S E C, Williamson E D, et al. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1 capsule positive and negative strains of Y. pestis. Infect Immun, 1996, 64(11): 4580-4585
14. Powell B S, Andrews G P, Enama J T, et al. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog, 2005, 21(5): 1490-1510
15. Williamson E D, Flick-Smith H C, LeButt C, et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun, 2005, 73(6): 3598-3608
16. Wang D, Huang S J, Xing L, et al. Purification and immuno-protection in BALB/c mice of recombinant F1-V fusion protein of Yersinia pestis. Prog Biochem Biophys (in Chinese), 2006, 33(3): 287-291.
17. Shu C L, Gao J Y, Peng H, et al. The immune reaction in mucosal and systemic immune system was induced after in tranasal immunization with bivalent Shigella vaccines. Chin J Immun (in Chinese), 2001, 17(10): 521-524
18. Pulendran B, Smith J L, Caspary G, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA, 1999, 96(3): 1036-1041
19. Jones S M, Day F, Stagg A J. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine, 2000, 19(2-3): 358-366
20. Chinese Pharmacopocia Commission of Biological Products Standardization. Regulations of Manufacture and Check of Plague Vaccine (Live) for Percutaneous Scarification (in Chinese). Beijing: Chemical Industry Press, 2005. 40-42